James A. Eastham, MD, FACS
Chief, Urology Service; Florence and Theodore Baumritter/Enid Ancell Chair of Urologic Oncology

James Eastham, Chief of Memorial Sloan-Kettering’s Urology Service, talks about how our prostate cancer experts collaborate to maximize the likelihood of curing the cancer and limiting the side effects of treatment.
I am a surgeon who specializes in nerve-sparing radical prostatectomy for the treatment of prostate cancer, and “salvage” radical prostatectomy in patients with prostate cancer in whom radiation therapy has failed.
My clinical research focuses on improving outcomes (such as cancer control, urinary continence, and sexual function) following surgery for prostate cancer. Together with my colleagues in medical oncology and radiation oncology, we attempt to tailor therapy more accurately to each individual's cancer in order to control cancer spread and decrease treatment-related side effects.
Prostate Cancer; Nerve-Sparing Techniques; Salvage Radical Prostatectomy; Robotic Prostatectomy
MD, University of Southern California
University of Southern California Medical Center
Baylor College of Medicine
Urology